Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Annals of Clinical and Translational Neurology
|
February 17, 2024
Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review
Patricia K Coyle, Mark S Freedman, Bruce A Cohen, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
May 12, 2009
The treatment of multiple sclerosis with inosine
Clyde E Markowitz, Sergei Spitsin, Vanessa Zimmerman, et al.
Journal of Palliative Medicine
|
May 3, 2007
Palliative care in amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis
Lauren B Elman, David J Houghton, Gregory F Wu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 8, 2013
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME
Aaron E Miller, Bruce A Cohen, Stephen C Krieger, et al.
Pharmacoepidemiology and Drug Safety
|
May 4, 2011
Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures
Hedi Schelleman, John R Pollard, Craig Newcomb, et al.
Neuro-Ophthalmology (Aeolus Press)
|
August 29, 2018
Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials
John L Keltner, Kimberly E Cello, Laura J Balcer, et al.
Journal of the Neurological Sciences
|
October 21, 2006
Treatment of Susac syndrome with gamma globulin and corticosteroids
Robert J Fox, Fiona Costello, Alexander R Judkins, et al.
American Journal of Ophthalmology
|
May 7, 2002
Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire
Siu-Ling Ma, Judy A Shea, Steven L Galetta, et al.
Radiology
|
October 2, 2002
Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations
Oded Gonen, David M Moriarty, Belinda S Y Li, et al.
Multiple Sclerosis and Related Disorders
|
November 14, 2018
Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control
Eli K Cehelyk, Denise Y Harvey, Meghan L Grubb, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Annals of Clinical and Translational Neurology
|
February 17, 2024
Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review
Patricia K Coyle, Mark S Freedman, Bruce A Cohen, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
May 12, 2009
The treatment of multiple sclerosis with inosine
Clyde E Markowitz, Sergei Spitsin, Vanessa Zimmerman, et al.
Journal of Palliative Medicine
|
May 3, 2007
Palliative care in amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis
Lauren B Elman, David J Houghton, Gregory F Wu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 8, 2013
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME
Aaron E Miller, Bruce A Cohen, Stephen C Krieger, et al.
Pharmacoepidemiology and Drug Safety
|
May 4, 2011
Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures
Hedi Schelleman, John R Pollard, Craig Newcomb, et al.
Neuro-Ophthalmology (Aeolus Press)
|
August 29, 2018
Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials
John L Keltner, Kimberly E Cello, Laura J Balcer, et al.
Journal of the Neurological Sciences
|
October 21, 2006
Treatment of Susac syndrome with gamma globulin and corticosteroids
Robert J Fox, Fiona Costello, Alexander R Judkins, et al.
American Journal of Ophthalmology
|
May 7, 2002
Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire
Siu-Ling Ma, Judy A Shea, Steven L Galetta, et al.
Radiology
|
October 2, 2002
Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations
Oded Gonen, David M Moriarty, Belinda S Y Li, et al.
Multiple Sclerosis and Related Disorders
|
November 14, 2018
Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control
Eli K Cehelyk, Denise Y Harvey, Meghan L Grubb, et al.
Page
of 4